Celine Castronuovo

The threat of a massive tax is enough to push drugmakers such as Boehringer Ingelheim Pharmaceuticals, Inc. and Novartis AG to comply with the Biden administration’s landmark drug pricing law and negotiate with Medicare.

Infusion therapy providers would be harmed if a federal judge dismisses a lawsuit challenging Medicare’s new drug price negotiation program, attorneys for a coalition of trade associations wrote in a filing Monday.

The FDA would have clear authority to regulate medical tests that come from a single laboratory under a proposal released by the agency Friday.

The Medicare agency may continue implementing its drug price negotiation program even as litigation over the plans play out in federal court, a judge ordered Friday.

Drugmaker Johnson & Johnson has agreed to negotiate drug prices with Medicare for its drugs Xarelto and Stelara, the company told Bloomberg Law Monday.

The Medicare agency must withdraw a Trump-era rule on copay assistance programs under a federal judge’s order following claims from drug industry-backed patient groups that the policy has allowed health plans to increase out-of-pocket prescription drug costs for consumers.

The state of Hawaii has joined the legal fray against the country’s top companies managing prescription drug benefits, alleging the entities are driving up high drug costs for patients they’re supposed to serve.

A wave of state boards aiming to set limits on what health plans pay for prescription drugs is likely to trigger lawsuits from drugmakers, policy analysts and lobbying groups say, as the industry also fights government price-setting policy at the federal level.

Robert F. Kennedy Jr.'s selection to serve as President-elect Donald Trump's top health official is prompting questions from policy watchers over how the pick will handle the range of key health policies that would fall under his purview.

WASHINGTON — Robert F. Kennedy Jr.'s selection to serve as President-elect Donald Trump's top health official is prompting questions from policy